What is the incidence of stent occlusion in the Left Anterior Descending (LAD) artery after placement of three stents?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Incidence of Stent Occlusion in LAD with Three Stents

When three stents are placed in the LAD, observational data suggest a significantly elevated risk of stent thrombosis and restenosis, though precise incidence rates are not well-defined in the literature—the ESC guidelines emphasize that DAPT should never be interrupted in these patients and surgical revascularization should be strongly considered instead of sequential stenting. 1

Key Clinical Evidence on Multiple Overlapping Stents

Acute and Mid-Term Outcomes

  • In-hospital complications occur in approximately 16.6% of patients receiving multiple overlapping drug-eluting stents (average 2.8 stents, mean length 80mm) in the LAD, primarily manifesting as non-Q-wave myocardial infarction. 2

  • Intraprocedural stent thrombosis occurred in 1.5% of cases (1 out of 66 patients) during the index procedure when multiple overlapping DES were placed in diffuse LAD disease. 2

  • At six-month follow-up, the hierarchical major adverse cardiac event rate was 15%, with target vessel revascularization required in 15% of patients treated with multiple overlapping stents in the LAD. 2

Critical Risk Factors with Multiple Stent Layers

The ESC guidelines explicitly state that having three stent layers in a single coronary lesion creates a high-risk scenario where DAPT interruption should never occur, even remotely from the intervention. 1 This recommendation stems from observational data suggesting substantially elevated thrombotic risk with multiple overlapping stents.

  • The need to sequentially stent one coronary lesion three times should prompt serious consideration of switching from PCI to CABG to obtain long-lasting vessel patency, particularly when the LAD is involved. 1

Comparison to Standard Single-Stent Outcomes

Proximal LAD Stenting (Single Stent)

  • Restenosis rates with single bare-metal stents in ostial LAD lesions are approximately 26.1% at six months, with target lesion revascularization rates of 11.7%. 3

  • Drug-eluting stents in the proximal LAD demonstrate superior outcomes compared to bare-metal stents, with hazard ratios of 0.39 for restenosis and 0.58 for mortality. 4

  • Stent thrombosis risk is higher in the proximal LAD compared to the left circumflex (HR 2.32, CI 1.11-4.85), though no difference exists compared to the RCA. 4

Critical Management Implications

Mandatory DAPT Duration

Patients with three overlapping stents in the LAD require prolonged or even lifelong DAPT if tolerated, as the risk of stent thrombosis remains substantially elevated. 1

  • After a first stent thrombosis event, the long-term risk of recurrent thrombosis is high, reinforcing the need for indefinite DAPT continuation. 1

  • Very late stent thrombosis can occur 20 months or more after implantation, even with newer-generation DES, particularly after DAPT discontinuation. 1

Surgical Revascularization Consideration

The requirement for three sequential stents in a single LAD lesion should trigger Heart Team discussion favoring CABG over continued PCI, especially given the LAD's critical territory and the compromised long-term patency with multiple stent layers. 1

  • Proximal LAD stenosis with complex anatomy is a Class I indication for considering CABG, which provides superior long-term vessel patency compared to multiple overlapping stents. 5

Common Clinical Pitfalls

Premature DAPT Discontinuation

Complete interruption of DAPT (discontinuation of both antiplatelet agents) is an independent predictor of stent thrombosis and mortality, particularly catastrophic in patients with multiple overlapping stents. 1, 6

  • Even for procedures requiring antiplatelet interruption, at least one agent (preferably aspirin) should be maintained if hemodynamically tolerable. 6

Underestimating Thrombotic Risk

The presence of three stent layers creates a uniquely high-risk substrate where standard risk stratification tools may underestimate true thrombotic risk. 1

  • Stent underexpansion or undersizing frequently contributes to stent thrombosis and should be assessed with imaging guidance (OCT or IVUS) when multiple stents are placed. 1

Failure to Consider Alternative Revascularization

Sequential stenting attempts that result in three stent layers represent a failure point where surgical revascularization should have been considered earlier to avoid the compounded risks of multiple metal layers. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Stent placement for ostial left anterior descending coronary artery stenosis: acute and long-term (2-year) results.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2000

Guideline

Management of LAD Lesions Detected on EKG

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Asymptomatic CAD with Prior GI Bleeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the risks of elective catheterization and stent placement for a Left Anterior Descending (LAD) artery lesion in a 76-year-old male with potential comorbid conditions such as Impaired renal function, diabetes, or previous stroke?
What is the life expectancy for a 76-year-old male with a stent for severe Left Anterior Descending (LAD) disease and no other comorbidities?
Can placement of a Left Anterior Descending (LAD) stent cause significant changes on a 12-lead Electrocardiogram (ECG)?
What are the potential complications of a cardiac catheterization and Left Anterior Descending (LAD) stent placement in an elderly patient?
How should I manage a patient with non-dominant left circumflex (LCx) artery disease, diseased Ramus, minor plaque in the distal left main coronary artery (LMCA), and diffuse disease in the proximal to moderate left anterior descending (LAD) artery after primary percutaneous transluminal coronary angioplasty (PTCA) with stenting to the right coronary artery (RCA)?
Is fluid resuscitation rate based on ideal body weight (IBW) or actual body weight (ABW)?
Can hepatitis cause liver cysts?
Is a CT scan of the sinuses medically necessary for a patient with postnasal drip, gagging, and choking?
What is the management of recurrent anemia in individuals with thalassemia trait requiring multiple transfusions?
Is elevated vitamin B12 (cobalamin) a concerning condition?
Are there any contraindications to using Cipro (ciprofloxacin) and Bactrim (trimethoprim/sulfamethoxazole) together?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.